Krankenkasse übernimmt PrEP gegen HIV: Experte sagt, wer profitiert
Das HIV-Medikament PrEP wird ab 2024 von der Krankenkasse bezahlt. Damit will die Schweiz Neuinfektionen verringern. Facharzt Benjamin Hampel im ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.